Gilead Puts Emergency Access to Experimental Coronavirus Drug on Hold Amid Surging Demand Gilead Puts Emergency Access to Experimental Coronavirus Drug on Hold Amid Surging Demand

Gilead Sciences Inc said on Sunday it was temporarily putting new emergency access to its experimental coronavirus drug remdesivir on hold due to overwhelming demand and that it wanted most people receiving the drug to participate in a clinical trial to prove if it is safe and effective.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news